Which has the lower trailing P/E, BMY or DHR?

BMY has the lower trailing P/E: BMY trades at 14.02 and DHR at 35.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or DHR?

Over the past five years, BMY grew revenue faster — BMY at a 2.08% CAGR versus DHR at 1.97%.

Does BMY or DHR pay a bigger dividend?

BMY yields 3.94% and DHR yields 0.72% based on trailing dividends and the latest price.

Is BMY or DHR more profitable?

BMY runs the higher net margin — BMY at 18.87% versus DHR at 15.95%.

How have BMY and DHR total returns compared?

Over the past 10 years, BMY delivered 5.01% and DHR delivered 11.94% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Danaher Corporation (DHR)

A side-by-side comparison of Bristol-Myers Squibb Company and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

DHR

Danaher Corporation

$140.64B

$200.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — BMY vs DHR

growth of $100 · dividends reinvested · last 10y

BMY +64.7% (+5.1%/yr)DHR +201.3% (+11.7%/yr)DHR compounded faster over this window

BMY DHR

BMY vs DHR: by the numbers

•DHR is the larger company ($140.64B vs $130.00B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 35.53 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 15.95% net margin).
•BMY grew revenue faster over the past five years (2.08% vs 1.97% CAGR).
•BMY pays the higher dividend yield (3.94% vs 0.72%).

Metrics side by side

Valuation

Metric	BMY	DHR
P/E ratio	14.02	35.53
Forward P/E	9.18	23.52
P/S ratio	2.64	5.60
P/B ratio	5.82	2.67
EV / EBITDA	9.71	22.54
FCF yield	8.80%	3.89%

Profitability

Metric	BMY	DHR
Gross margin	70.16%	58.51%
Operating margin	28.27%	20.42%
Net margin	18.87%	15.95%
ROE	41.59%	7.61%
ROIC	15.47%	5.03%

Dividends

Metric	BMY	DHR
Dividend yield	3.94%	0.72%
Payout ratio	55.29%	25.58%

Growth (annualized)

Metric	BMY	DHR
Revenue CAGR (5Y)	2.08%	1.97%
EPS CAGR (5Y)	9.38%	0.40%
FCF CAGR (5Y)	-0.95%	-2.83%
Total return CAGR (5Y)	4.39%	-6.82%

Frequently asked

Which has the lower trailing P/E, BMY or DHR?: BMY has the lower trailing P/E: BMY trades at 14.02 and DHR at 35.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or DHR?: Over the past five years, BMY grew revenue faster — BMY at a 2.08% CAGR versus DHR at 1.97%.
Does BMY or DHR pay a bigger dividend?: BMY yields 3.94% and DHR yields 0.72% based on trailing dividends and the latest price.
Is BMY or DHR more profitable?: BMY runs the higher net margin — BMY at 18.87% versus DHR at 15.95%.
How have BMY and DHR total returns compared?: Over the past 10 years, BMY delivered 5.01% and DHR delivered 11.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full DHR analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Danaher P/E ratio Bristol-Myers Squibb dividend yield Danaher dividend yield Bristol-Myers Squibb ROE Danaher ROE Bristol-Myers Squibb operating margin Danaher operating margin Bristol-Myers Squibb revenue growth Danaher revenue growth Bristol-Myers Squibb free cash flow Danaher free cash flow

Bristol-Myers Squibb & Danaher appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.